---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-073338"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:32:33.265631+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Blade sells passenger division to Joby for up to $125M; to rebrand as Strata

## Summary
- Up to $125M consideration (cash or Joby stock): $90M at close plus up to $35M earnout tied to performance and retention.
- Blade's medical division remains public and rebrands as Strata, focusing on contractual medical logistics and organ transport.
- CEO Rob Wiesenthal joins Joby as CEO of Blade unit, becomes Chairman of Strata; co-CEOs Tomkiel and Heyburn lead Strata.
- Transaction expected to be Adjusted EBITDA and FCF neutral; $7M in annual corporate cost efficiencies identified.
- Expected close in coming weeks; Blade's Passenger business includes US/Europe operations and the Blade brand.

## SEC filing metadata
- accession: 0001104659-25-073338
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000110465925073338/0001104659-25-073338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000110465925073338/tm2522427d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-073338
- JSON: https://secwatch.observer/filing/0001104659-25-073338.json
- Plain text: https://secwatch.observer/filing/0001104659-25-073338.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.